Clinical Trial

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a multi-center, randomized controlled, prospective clinical study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Status change: Not Yet Recruiting → Recruiting 2025-12-22
Trial Details
NCT Number NCT07248956
Lead Sponsor Eye & ENT Hospital of Fudan University
Conditions Hypopharyngeal Carcinoma
Enrollment 116 participants
Start Date 2025-12-22
Primary Completion 2027-11-30 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-23